許正宇:考慮就港股通人民幣計價南向交易設套戥便利措施
證監會、金管局與港交所(00388.HK)成立工作小組,就容許港股通南向交易的股票以人民幣計價的可行性進行研究。財經事務及庫務局局長許正宇表示,相關項目未有具體執行時間表。他提到,南向交易倘設人民幣櫃檯,將涉及規則修訂、技術配合,以及更新與系統提升,當局亦會考慮兩個櫃檯之間是否有套戥便利措施令價格趨同。
另外,積金易平台最快今年底完成設計,明年4月起供14個受託人公司分階段過渡到平台。財經事務及庫務局常任秘書長(財經事務)甄美薇表示,已要求積金易平台承辦商開始與僱員及僱主測試有關設計的運用;14個受託人將會分階段上線,不會出現上線後部分運作仍沿用舊方式的情況,目標爭取平台在2025年初全面運作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.